As consistently observed in previous studies, the ability of PGE2 to stimulate aromatase activity in proximal and tumour fibroblasts (520 and 100%, respectively) was considerably lower than that achieved with IL-6+IL-6sR (960 and 710%, respectively). The gene discussed is IL6; the disease is neoplasm.